The round was led by Prime Movers Lab, including investment from Westcott Investment Group, Dolby Family Ventures, Synergy Ventures, Pureland Global Venture, IT-Farm, and Alpha Edison.

Paradromics is developing brain-machine interface (BMI) technology that is designed to allow patients with severe connectivity disorders such as blindness, deafness and paralysis to reconnect with the outside world using advanced prosthetic devices. One of the initial applications of this potentially life-changing technology will be to enable locked-in patients who are unable to fluently communicate, to speak again in real time via the aid of a computer.